Benefit Plans (Tables)

12 Months Ended

Jun. 30, 2020

Benefit Plans

Schedule of changes in the number of shares available for grant under equity incentive plans

	Number of Shares
Available for grant at July 1, 2019	9,759
RSUs granted	(658)
Shares withheld in settlement of taxes and/or exercise price	385
Forfeitures	110
Shares removed	(77)
Available for grant at June 30, 2020	9,519

Schedule of stock-based compensation expense related to stock options, restricted stock units and the Employee Stock Purchase Plan

	Year ended June 30,
	2018		2019		2020
Cost of revenues	$	4,218	$	5,027	$	5,637
Sales and marketing		7,295		7,631		13,960
Research and development		3,748		5,325		7,182
General and administrative		15,093		20,782		20,714
Total stock-based compensation expense	$	30,354	$	38,765	$	47,493

Schedule of stock option activity

	Outstanding Options
				Weighted
		Weighted		average
		average		remaining	Aggregate
	Number of	exercise		contractual	intrinsic
	shares	price		term (years)	value
Balance at July 1, 2019	1,525	$	12.24	3.95	$	124,373
Options exercised	(270)	$	11.39
Balance at June 30, 2020	1,255	$	12.43	2.96	$	167,406
Options vested and exercisable at June 30, 2020	1,255	$	12.43	2.96	$	167,406

Schedule of restricted stock unit activity

	Units	Weighted average grant date fair value
RSU balance at July 1, 2019	1,813	$	53.78
RSUs granted	658	$	99.72
RSUs vested	(735)	$	50.25
RSUs forfeited	(110)	$	62.60
RSU balance at June 30, 2020	1,626	$	73.96
RSUs expected to vest at June 30, 2020	1,448	$	72.15

Schedule of weighted average assumptions used for estimating grant date fair value of the ESPP

	Year ended June 30,
	2018		2019		2020
Valuation assumptions:
Expected dividend yield	0	%	0	%	0	%
Expected volatility	28.3 - 39.1	%	33.5 - 38.6	%	38.6 - 72.2	%
Expected term (years)	0.5		0.5		0.5
Risk‑free interest rate	1.02 - 2.10	%	2.10 - 2.48	%	0.15 - 2.44	%